Neochlorogenic acid enhances the antitumor effects of pingyangmycin via regulating TOP2A

Che,Jianhuan; Zhao,Tongxia; Liu,Wen; Chen,Shi; Yang,Guangyu; Li,Xinyan; Liu,Dongling

doi:10.3892/mmr.2020.11797

Neochlorogenic acid enhances the antitumor effects of pingyangmycin via regulating TOP2A

Authors:
- Jianhuan Che
- Tongxia Zhao
- Wen Liu
- Shi Chen
- Guangyu Yang
- Xinyan Li
- Dongling Liu
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China, Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Otorhinolaryngology Head and Neck Surgery, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: December 22, 2020 https://doi.org/10.3892/mmr.2020.11797
Article Number: 158

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neochlorogenic acid (NCA), a natural compound found in honeysuckle, possesses prominent anti‑inflammatory and antitumor effects. Pingyangmycin (PYM) induces DNA damage and has been used for the treatment of oral and maxillofacial tumors. Oral care serves an important role in promoting wound healing during chemotherapy in patients with oral squamous cell carcinoma (OSCC). Therefore, the present study aimed to analyze the effects of NCA and PYM on OSCC cells and to investigate the potential underlying mechanism. Reverse transcription‑quantitative PCR and western blotting were conducted to analyze the expression levels of DNA topoisomerase II α (TOP2A) in different OSCC cell lines. TOP2A‑overexpression cells were constructed via transfection of TOP2A‑overexpression plasmids. Following NCA or PYM treatment, cell proliferation was assessed using Cell Counting Kit‑8 and colony formation assays, whereas cell apoptosis and the cell cycle distribution were assessed via TUNEL staining and flow cytometry, respectively. In addition, the expression levels of apoptosis‑ and cell cycle‑related proteins were detected via western blotting. Moreover, co‑immunoprecipitation (Co‑IP) was conducted to determine whether TOP2A interacted with CDK1. The results of the present study indicated that NCA treatment significantly enhanced the suppressive effects of PYM on OSCC cell proliferation and apoptosis. The results also indicated that PYM arrested the cell cycle in the G₀/₁ by regulating cyclin dependent kinase 1 (CDK1)/cyclin B1, which was enhanced by the cotreatment of NCA and PYM. In addition, NCA and PYA treatment altered the expression levels of apoptosis‑related proteins. The Co‑IP assay indicated that TOP2A interacted with CDK1. Moreover, TOP2A overexpression significantly reversed the effects of NCA and PYM treatment on OSCC cell proliferation and apoptosis. In addition, NCA significantly decreased PYM‑induced toxicity in normal oral epithelial cells. In conclusion, the results of the present study suggested that NCA may promote the inhibitory effects of PYM in OSCC via TOP2A.

View Figures

View References

1	Gong JH, Liu XJ, Li Y and Zhen YS: Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice. Cancer Chemother Pharmacol. 69:1323–1332. 2012. View Article : Google Scholar : PubMed/NCBI
2	He Y, Lan Y, Liu Y, Yu H, Han Z, Li X and Zhang L: Pingyangmycin and bleomycin share the same cytotoxicity pathway. Molecules. 21:8622016. View Article : Google Scholar
3	Chen J and Stubbe J: Bleomycins: Towards better therapeutics. Nat Rev Cancer. 5:102–112. 2005. View Article : Google Scholar : PubMed/NCBI
4	Tai KW, Chang YC, Chou LS and Chou MY: Cytotoxic effect of pingyangmycin on cultured KB cells. Oral Oncol. 34:219–223. 1998. View Article : Google Scholar : PubMed/NCBI
5	Sun ML, Wang CM and Wen YM: Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 28:257–260. 2010.(In Chinese). PubMed/NCBI
6	Zhang L, Chen F, Zheng J, Wang H, Qin X and Pan W: Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: Design, optimization and in vitro and in vivo studies. Drug Deliv. 25:690–702. 2018. View Article : Google Scholar : PubMed/NCBI
7	Tu JB, Li QY, Jiang F, Hu XY, Ma RZ, Dong Q, Zhang H, Pattar P and Li SX: Pingyangmycin stimulates apoptosis in human hemangioma-derived endothelial cells through activation of the p53 pathway. Mol Med Rep. 10:301–305. 2014. View Article : Google Scholar : PubMed/NCBI
8	Ning ZW, Zhai LX, Peng J, Zhao L, Huang T, Lin CY, Chen WH, Luo Z, Xiao HT and Bian ZX: Simultaneous UPLC-TQ-MS/MS determination of six active components in rat plasma: Application in the pharmacokinetic study of Cyclocarya paliurus leaves. Chin Med. 14:282019. View Article : Google Scholar : PubMed/NCBI
9	Cho HD, Kim JH, Won YS, Moon KD and Seo KI: Inhibitory effects of pectinase-treated Prunus mume fruit concentrate on colorectal cancer proliferation and angiogenesis of endothelial cells. J Food Sci. 84:3284–3295. 2019. View Article : Google Scholar : PubMed/NCBI
10	Sitarek P, Kowalczyk T, Santangelo S, Bialas AJ, Toma M, Wieczfinska J, Sliwinski T and Skala E: The extract of Leonurus sibiricus transgenic roots with AtPAP1 transcriptional factor induces apoptosis via DNA damage and down regulation of selected epigenetic factors in human cancer cells. Neurochem Res. 43:1363–1370. 2018. View Article : Google Scholar : PubMed/NCBI
11	de Carvalho MC, Barca FN, Agnez-Lima LP and de Medeirost SR: Evaluation of mutagenic activity in an extract of pepper tree stem bark (schinus terebinthifolius raddi). Environ Mol Mutagen. 42:185–191. 2003. View Article : Google Scholar : PubMed/NCBI
12	Garcia-Carbonero R and Supko JG: Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res. 8:641–661. 2002.PubMed/NCBI
13	Chen AY and Liu LF: DNA topoisomerases: Essential enzymes and lethal targets. Ann Rev Pharmacol Toxicol. 34:191–218. 1994. View Article : Google Scholar
14	Pendleton M, Lindsey RH, Felix CA, Grimwade D and Osheroff N: Topoisomerase II and leukemia. Ann N Y Acad Sci. 1310:98–110. 2014. View Article : Google Scholar : PubMed/NCBI
15	Ni W, Zhang S, Jiang B, Ni R, Xiao M, Lu C, Liu J, Qu L, Ni H, Zhang W and Zhou P: Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation. Pathol Res Pract. 215:1524282019. View Article : Google Scholar : PubMed/NCBI
16	Liu L, Lin J and He H: Identification of potential crucial genes associated with the pathogenesis and prognosis of endometrial cancer. Front Genet. 10:3732019. View Article : Google Scholar : PubMed/NCBI
17	Lawal AO, Adisa AO and Effiom OA: A review of 640 oral squamous cell carcinoma cases in Nigeria. J Clin Exp Dent. 9:e767–e771. 2017.PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Li Pei, Yang Cheng, GU Xiaoming, et al: Relationship between the expression of KI-67, VEGF and P16 and the efficacy of pingyangmycin induced chemotherapy in oral squamous cell carcinoma. 22:89–92
20	Ding HC: Pingyangmycin in the treatment of oral squamous cell carcinoma: Effects and side effects. J Applied Stomatol. 1:3–5. 1998.
21	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
22	Peterson DE, Jones JB and Petit RG II: Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer. 109:322–331. 2007. View Article : Google Scholar : PubMed/NCBI
23	Madan PD, Sequeira PS, Shenoy K and Shetty J: The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: A randomized control trial. J Cancer Res Ther. 4:3–8. 2008. View Article : Google Scholar : PubMed/NCBI
24	Iwamoto M, Morikawa T, Narita M, Shibahara T and Katakura A: Investigation of surgical site infections and bacteria detected following neck dissection in patients with oral cancer. Bull Tokyo Dent Coll. 61:1–7. 2020. View Article : Google Scholar : PubMed/NCBI
25	Li W, Jinyi L, Weiqi F, Xiangjin Z, Liwen R, Shiwei L, Jinhua W, Tengfei J and Guanhua D: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. J Exp Clin Cancer Res. 37:1322018. View Article : Google Scholar : PubMed/NCBI
26	Liu D, Zhao J, Sun H, He S, Wang J and Zhang Q: Preparation technology of an antibacterial mouthwash. J Food Safety Quality Inspection. 10:638–644. 2019.
27	Chaowuttikul C, Palanuvej C and Ruangrungsi N: Pharmacognostic specification, chlorogenic acid content, and in vitro antioxidant activities of Lonicera japonica flowering bud. Pharmacognosy Res. 9:128–132. 2017.PubMed/NCBI
28	Ye LH, Du LJ and Cao J: Fatty acids-based microemulsion liquid chromatographic determination of multiple caffeoylquinic acid isomers and caffeic acid in honeysuckle sample. J Pharm Biomed Anal. 171:22–29. 2019. View Article : Google Scholar : PubMed/NCBI
29	Chaovanalikit A, Thompson MM and Wrolstad RE: Characterization and quantification of anthocyanins and polyphenolics in bluehHoneysuckle (Lonicera caerulea L.). J Agric Food Chem. 52:848–852. 2004. View Article : Google Scholar : PubMed/NCBI
30	Zhao Z, Shin HS, Satsu H, Totsuka M and Shimizu M: 5-caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-alpha-induced secretion of interleukin-8 from Caco-2 cells. J Agric Food Chem. 56:3863–3868. 2008. View Article : Google Scholar : PubMed/NCBI
31	Fang W, Ma Y, Wang J, Yang X, Gu Y and Li Y: In vitro and in vivo antitumor activity of neochlorogenic acid in human gastric carcinoma cells are complemented with ROS generation, loss of mitochondrial membrane potential and apoptosis induction. J BUON. 24:221–226. 2019.PubMed/NCBI
32	De Maria CAB, Moreira Santos MC, José De Lima Dias U and Marana M: Stabilization of soybean oil with heated quercetin and 5-caffeoylquinic acid in the presence of ferric ion. J Agric Food Chem. 48:3935–3938. 2000. View Article : Google Scholar : PubMed/NCBI
33	Hossain MA, Asa TA, Rahman MM, Uddin S, Moustafa AA, Quinn JMW and Moni MA: Network-based genetic profiling reveals cellular pathway differences between follicular thyroid carcinoma and follicular thyroid adenoma. Int J Environ Res Public Health. 17:13732020. View Article : Google Scholar
34	Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, et al: Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. J Immunother Cancer. 7:272019. View Article : Google Scholar : PubMed/NCBI
35	Xue JM, Liu Y, Wan LH and Zhu YX: Comprehensive analysis of differential gene expression to identify common gene signatures in multiple cancers. Med Sci Monit. 26:e9199532020. View Article : Google Scholar : PubMed/NCBI
36	Coelho PA, Queiroz-Machado J, Carmo AM, Moutinho-Pereira S, Maiato H and Sunkel CE: Dual role of topoisomerase II in centromere resolution and aurora B activity. PLoS Biol. 6:e2072008. View Article : Google Scholar : PubMed/NCBI
37	Ben-Shlomo R: Chronodisruption, cell cycle checkpoints and DNA repair. Indian J Exp Biol. 52:399–403. 2014.PubMed/NCBI
38	Sasaki M, Terabayashi T, Weiss SM and Ferby I: The tumor suppressor MIG6 controls mitotic progression and the G2/M DNA damage checkpoint by stabilizing the WEE1 kinase. Cell Rep. 24:1278–1289. 2018. View Article : Google Scholar : PubMed/NCBI
39	Satyanarayana A and Kaldis P: Mammalian cell-cycle regulation: Several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene. 28:2925–2939. 2009. View Article : Google Scholar : PubMed/NCBI
40	Qiao L, Zhang Q, Zhang W and Chen JJ: The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1. J Cell Mol Med. 22:5333–5345. 2018. View Article : Google Scholar : PubMed/NCBI
41	Fan X and Chen JJ: Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene. Cell Cycle. 13:3249–3259. 2014. View Article : Google Scholar : PubMed/NCBI
42	Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M and Slaby O: Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget. 7:622–637. 2016. View Article : Google Scholar : PubMed/NCBI
43	Kulisic-Bilusic T, Schnäbele K, Schmöller I, Dragovic-Uzelac V, Krisko A, Dejanovic B, Milos M and Pifat G: Antioxidant activity versus cytotoxic and nuclear factor kappa B regulatory activities on HT-29 cells by natural fruit juices. Eur Food Res Technol. 228:417–424. 2009. View Article : Google Scholar
44	Gao XH, Zhang SD, Wang LT, Yu L, Zhao XL, Ni HY, Wang YQ, Wang JD, Shan CH and Fu YJ: Anti-inflammatory effects of neochlorogenic acid extract from mulberry leaf (Morus alba L.) against LPS-stimulated inflammatory response through mediating the AMPK/Nrf2 signaling pathway in A549 cells. Molecules. 25:13852020. View Article : Google Scholar
45	Li C, Huang G, Tan F, Zhou X, Mu J, Zhao X and Giaouris E: In vitro analysis of antioxidant, anticancer, and bioactive components of Apocynum venetum tea extracts. J Food Quality. 2019:1–13. 2019. View Article : Google Scholar
46	Merrill CL, Ni H, Yoon LW, Tirmenstein MA, Narayanan P, Benavides GR, Easton MJ, Creech DR, Hu CX, McFarland DC, et al: Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. Toxicol Sci. 68:93–101. 2002. View Article : Google Scholar : PubMed/NCBI
47	Xiao H, Xu D, Chen P, Zeng G, Wang X and Zhang X: Identification of five genes as a potential biomarker for predicting progress and prognosis in adrenocortical carcinoma. J Cancer. 9:4484–4495. 2018. View Article : Google Scholar : PubMed/NCBI
48	Zhou Z, Li Y, Hao H, Wang Y, Zhou Z, Wang Z and Chu X: Screening hub genes as prognostic biomarkers of hepatocellular carcinoma by bioinformatics analysis. Cell Transplant. 28 (Suppl 1):S76–S86. 2019. View Article : Google Scholar
49	Zhao ZW, Fan XX, Yang LL, Song JJ, Fang SJ, Tu JF, Chen MJ, Zheng LY, Wu FZ, Zhang DK, et al: The identification of a common different gene expression signature in patients with colorectal cancer. Math Biosci Eng. 16:2942–2958. 2019. View Article : Google Scholar : PubMed/NCBI
50	Pan Z, Li L, Fang Q, Qian Y, Zhang Y, Zhu J, Ge M and Huang P: Integrated bioinformatics analysis of master regulators in anaplastic thyroid carcinoma. Biomed Res Int. 2019:97345762019. View Article : Google Scholar : PubMed/NCBI
51	Zhu X, Wang D, Lin Q, Wu G, Yuan S, Ye F and Fan Q: Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA-mRNA functional synergistic network. Cancer Med. 8:3875–3891. 2019. View Article : Google Scholar : PubMed/NCBI
52	Menon DR, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC, et al: CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma. Cancer Res. 78:6561–6574. 2018. View Article : Google Scholar : PubMed/NCBI
53	Lim S and Kaldis P: Cdks, cyclins and CKIs: Roles beyond cell cycle regulation. Development. 140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
54	Gan W, Zhao H, Li T, Liu K and Huang J: CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway. Oncotarget. 8:71618–71629. 2017. View Article : Google Scholar : PubMed/NCBI